EMCDDA

Comorbidity of mental health and substance use disorders

Website
Overview Mental health problems are very common in those with a substance use disorder, and these patients have more clinically and psychosocially severe problems than patients with substance use disorders without comorbid mental health...

A foresight toolkit for the drugs field

Guide
This toolkit aims to support the EMCDDA’s stakeholders, other actors and researchers in the drugs field to implement their own foresight exercise in the form of an introductory trend-based workshop. It describes briefly the foresight and...

New psychoactive substances (NPS)

Website
Overview A new psychoactive substance (NPS) is defined as 'a new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the United Nations drug conventions, but which may pose a public health threat...

European Drug Report 2022

Book
 - 
Summary The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across...

Prisons and drugs: health and social responses

Guide
 - 
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of what to consider when planning or delivering health and social responses to drug...
EMCDDA

Schools and drugs: health and social responses

Guide
 - 
A new handy mini guide by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on evidence-based policymaking for prevention of drug use in schools and educational settings.
EMCDDA